Zinc and Vitamin E: study protocols
77 study groups took Zinc together with Vitamin E. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Zinc
77 study groups in 65 studies say how much Zinc participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 10 mg to 25 mg, 42% of 77 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg or less | 3 |
| 5 mg to 10 mg | 10 |
| 10 mg to 25 mg | 32 |
| 25 mg to 50 mg | 13 |
| 50 mg to 100 mg | 15 |
| 100 mg to 250 mg | 4 |
Dose per serving from research: Vitamin E
47 study groups in 43 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 34% of 47 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg or less | 3 |
| 5 mg to 10 mg | 6 |
| 10 mg to 25 mg | 9 |
| 25 mg to 50 mg | 16 |
| 50 mg to 100 mg | 2 |
| 100 mg to 250 mg | 5 |
| 250 mg to 500 mg | 3 |
| 500 mg to 1 g | 3 |
Commonly used together
74 of 77 study groups took Zinc and Vitamin E with something else. Shown: what 3 or more different studies gave. The 10 most common of 23.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin C | 70 |
| Beta-Carotene | 34 |
| Selenium | 34 |
| Copper | 30 |
| Vitamin A | 16 |
| Iron | 13 |
| Vitamin B6 | 12 |
| Vitamin D | 12 |
| Niacin | 11 |
| Vitamin B12 | 11 |
77 study groups
| Study | ||||
|---|---|---|---|---|
| Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis 2016 · combination of antioxidants and zinc · Adults aged 55 years and older with age-related macular degeneration; eyes with advanced disease at baseline and participants with no AMD in both eyes were excluded | 80 mg | 400 IU | 2409 days | — |
| [Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy] 1993 · antioxidant group · Patients with acute alcohol-toxic hepatitis, clinical Child/Pugh severity grades B and C; age and sex not reported | 12 mg | 600 mg | — | 31 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 7.8 mg | 7.5 mg | 1 year | 316 |
| Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial 2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up | 30 mg | 30 mg | 5 years | 164 |
| Difensil Immuno Reduces Recurrence and Severity of Tonsillitis in Children: A Randomized Controlled Trial 2020 · Group B (GB) · Children younger than 8 years with at least 3 fever-associated tonsillitis episodes per year and Mackenzie score >2 | 11.2 mg | 45 mg | 45 days | 41 |
| Difensil Immuno Reduces Recurrence and Severity of Tonsillitis in Children: A Randomized Controlled Trial 2020 · Group A (GA) · Children younger than 8 years with at least 3 fever-associated tonsillitis episodes per year and Mackenzie score >2 | 7.5 mg | 30 mg | 90 days | 40 |
| Effects of perioperative vitamin E and zinc co-supplementation on systemic inflammation and length of stay following coronary artery bypass graft surgery: a randomized controlled trial 2024 · intervention group · Patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass; age and sex not reported | 30 mg | 200 IU | 3 weeks | 40 |
| Megadose vitamins in bladder cancer: a double-blind clinical trial 1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy | 90 mg | — | — | 35 |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 20 mg | 30 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 80 mg | 400 IU | 8 years | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 20 mg | 8 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 30 mg | 10 mg | — | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 80 mg | 400 IU | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 20 mg | 30 mg | 2739 days | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 20 mg | 30 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 20 mg | 30 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 20 mg | 30 mg | 2738 days | — |
| Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa 2009 · multiple micronutrients · children aged 6–24 months; three cohorts: HIV-infected children, HIV-uninfected children born to HIV-infected mothers, and HIV-uninfected children born to HIV-uninfected mothers | 10 mg | 6 mg | 548 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 20 mg | 30 mg | 2738 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 80 mg | 400 IU | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 80 mg | 400 IU | 9 years | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 20 mg | 15 mg | 2 years | — |
| Effect of preventive supplementation with zinc and other micronutrients on non-malarial morbidity in Tanzanian pre-school children: a randomized trial 2012 · Multi-nutrients with zinc · Children aged 6–60 months with height-for-age z-score ≤−1.5 SD, in rural Tanzania | 10 mg | — | — | 151 |
| Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial 2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD) | 25 mg | 400 mg | 17 weeks | 26 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MV · Patients with type 2 diabetes | 20 mg | 100 mg | 120 days | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 7.8 mg | 7.5 mg | 1 year | 316 |
| Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months 2010 · Multiple micronutrients · Children enrolled at 6 months and followed to 24 months in rural South Africa; HIV-infected and HIV-uninfected children, both sexes | 10 mg | 6 mg | 548 days | 126 |
| Effect of zinc supplementation on observed activity in low socioeconomic Indian preschool children 1996 · zinc group · Children aged 12–23 months from a low-socioeconomic urban population in New Delhi | 10 mg | — | — | 48 |
| Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial 2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly | 8 mg | 30 mg | 12 weeks | 40 |
| TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD 2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye | 69.6 mg | 200 IU | 24 weeks | 37 |
| A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study 2019 · verum group · Women aged 35–73 with healthy skin | 3 mg | 2.3 mg | 12 weeks | 36 |
| Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy 2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years | 5 mg | 15 mg | 26 weeks | 36 |
| Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study 2006 · Colostrum + Micronutrients · Healthy, non-smoking men and women aged 40–80 years | 15 mg | 200 mg | 10 weeks | 35 |
| Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study 2006 · Micronutrients · Healthy, non-smoking men and women aged 40–80 years | 15 mg | 200 mg | 10 weeks | 31 |
| A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement 2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease | 3 mg | 2.3 mg | 12 weeks | 30 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 22.5 mg | 30 mg | 1 year | 15 |
| The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise 2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day | 7.5 mg | 400 IU | 4 weeks | 10 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 20 mg | 100 mg | 120 days | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 20 mg | 30 mg | 2922 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group MV · People with type 2 diabetes; age and sex not reported | 30 mg | 150 mg | 90 days | 17 |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 200 mg | 600 mg | 8 weeks | — |
| Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration 2014 · Group 2 (Vitalux AREDS) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment | 25 mg | 400 IU | — | 10 |
| The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7 2002 · antioxidants and zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration | 80 mg | 400 IU | 5 years | — |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group MV · Adults with type 2 diabetes; age and sex not reported | 30 mg | 150 mg | 90 days | 17 |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 12 mg | 15 mg | 165 days | 749 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 12 mg | 15 mg | — | 176 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 30 mg | 20 mg | 184 days | 75 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 30 mg | 20 mg | 184 days | 75 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 50 mg | 250 IU | 180 days | 52 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 25 mg | 250 IU | 180 days | 47 |
| The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes 2019 · Zinc gluconate plus vitamin E · Women aged 18–40 with gestational diabetes mellitus | 233 mg | 400 IU | 6 weeks | 27 |
| High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy 2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery | 50 mg | 400 IU | 60 days | 26 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men | 34.8 mg | — | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men | 69.6 mg | — | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 69.6 mg | 400 mg | 1 day | 15 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 150 mg | 300 mg | 48 weeks | 11 |
| Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial 2001 · Selenium with alpha-tocopherol and zinc · Critically ill trauma patients, mean age 42 years, with severe multiple injury | 13 mg | 150 mg | 5 days | — |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 20 mg | 30 mg | 2 years | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 20 mg | 30 mg | 3 weeks | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 20 mg | 15 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 20 mg | 15 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 20 mg | 15 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 20 mg | 30 mg | 26 weeks | — |
| Multiple micronutrient supplementation improves micronutrient status in primary school children in Hai Phong City, Vietnam: a randomised controlled trial 2021 · intervention · Children aged 6–9 years, apparently healthy, in rural Hai Phong City, Vietnam; included undernourished, normal-weight, and overweight/obese children | 10 mg | 5 mg | 22 weeks | 175 |
| Effects of Perioperative Zinc Supplementation on Copper Circulating Levels and Expression of Metallothionein and Copper Antioxidant Chaperone-1 in Leukocytes in Patients Undergoing CABG Surgery 2025 · zinc-vitamin E group · Patients undergoing coronary artery bypass graft (CABG) surgery; age and sex not specified | 150 mg | — | 22 days | 40 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group MV · Patients with type 2 diabetes; age range and sex not specified | 30 mg | 100 IU | 90 days | 17 |
| Oxidative stress in humans during work at moderate altitude 1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 30 mg | — | 4 weeks | 15 |
| Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration 2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment | 25 mg | 400 IU | — | 10 |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 30 mg | 400 IU | 2 weeks | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 20 mg | 30 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 80 mg | 400 IU | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 60 mg | 800 mg | 120 days | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 80 mg | 400 IU | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 80 mg | 400 IU | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 80 mg | 400 IU | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 25 mg | 400 IU | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 25 mg | 400 IU | 5 years | — |